Jonathan J. Lipman Ph.D.

Areas of expertise include all areas of pharmacology with emphasis on neuropharmacology, psychoactive drugs, intoxication, drug-drug interactions, substance abuse and drug effects on behavior. Research interests include pain, addiction and opiate drug effects including adverse effects and stimulant drug psychotoxicity. Consultations offered include litigation support in cases of disability evaluation, response of the brain injured and psychiatrically impaired to drugs, therapeutic and otherwise, drug effects in criminal defendants and witnesses to and victims of crime.

Past consultations have involved: addiction behavior; addiction diseases; alcohol abuse; drug abuse; amphetamines; anesthetics, benzodiazepines, carbon monoxide poisoning; solvent / inhalant intoxication, cardiac pharmacology; cardiovascular pharmacology; chronic pain; clinical nutrition; cocaine; conduct disorder; drug-drug and drug-food interactions, deviant behavior; dietary supplements; disability evaluation; drug delivery; drug epidemiology; drug safety; drug toxicology; ephedra / ephedrine products; fetal alcohol syndrome; forensic toxicology; heroin; informed consent; LSD; marijuana; medical ethics; medical marijuana; methadone; medical toxicology; neurodevelopmental outcomes; neuropsychopharmacology; opioids; pain management; pediatric pharmacology; PCP; pharmacokinetics; pharmacological mechanisms; prescribing errors; psychotropic pharmaceuticals; toxic inhalations; victim behavior, violence, homicide, witness memory.

PhD Neuropharmacology, Fellow of the Royal Society of Medicine, certified in Pain Management, Forensic Examination, Substance Abuse and other branches of clinical pharmacology